Prednisone and Pregnancy
Links shared publicly online about this topic
Celgene to discontinue docetaxel and prednisone plus lenalidomide Phase III trial on CRPC
news-medical.net — “Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that based on the recommendation from the Data Monitoring Committee (DMC) it will discontinue its pivotal double-blinded Phase III MAINSAIL trial that was designed to evaluate the efficacy and safety of docetaxel and prednisone with or without lenalidomide in patients with castrate-resistant prostate cancer.” View full resource at news-medical.net
Most Recently Shared on November 23, 2011 at 6:35 am By:
Cancer News Celgene to discontinue docetaxel and prednisone plus lenalidomide Phase III trial on CRPC: Celgene I... http://t.co/rlNlXldU
NEJM publishes ZYTIGA plus prednisone Phase 3 trial data in metastatic castration-resistant prostate cancer
news-medical.net — “A study titled "Abiraterone and Increased Survival in Metastatic Prostate Cancer," published in the May 26 issue of NEJM, found that patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel showed a significant improvement in overall survival when treated with ZYTIGA plus prednisone compared to patients treated with prednisone plus placebo.” View full resource at news-medical.net
Most Recently Shared on May 26, 2011 at 5:33 am By:
News-Medical.Net Oncology and Health News
Oncology News: NEJM publishes ZYTIGA plus prednisone Phase 3 trial data in metastatic castration-resistant prost... http://bit.ly/iXbhEs
Celgene announces results of REVLIMID, docetaxel/prednisone phase II combination study on mCRPC
news-medical.net — “Celgene International Sàrl today announced results from a phase II investigator initiated study of REVLIMID (lenalidomide) in combination with Avastin (bevacizumab), docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer were presented at the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, Ill.” View full resource at news-medical.net
Most Recently Shared on June 6, 2011 at 9:16 am By:
Celgene announces results of REVLIMID, docetaxel/prednisone phase II combination study on mCRPC: Celgene Interna... http://bit.ly/iv3sF9
Clinical data from investigational study of patients with multiple myeloma presented at ASCO
news-medical.net — “Celgene International Sàrl announced clinical data from an investigational study of patients with multiple myeloma who were younger than 65 years old and received either lenalidomide (REVLIMID), melphalan and prednisone or melphalan plus autologous stem cell transplant (MEL200) following an induction treatment of lenalidomide plus low-dose dexamethasone (Rd) were presented at the American Society of Clinical Oncology annual meeting.” View full resource at news-medical.net
Most Recently Shared on June 12, 2010 at 12:57 am By:
Pregnancy News: Clinical data from investigational study of patients with multiple myeloma presented at ASCO... http://tinyurl.com/38jzqz8
Treatment of Psoriasis with Anti-TNF Drugs during Pregnancy: Case Report and Review of the Literature
content.karger.com — “Published experiences of TNF- inhibition during pregnancy consist of a limited number of case reports, series and ongoing registry data in patients with arthritis and inflammatory bowel disease. A 28-year-old woman -- with psoriasis vulgaris since she was 8 years of age and generalized pustular psoriasis during her first pregnancy (partially controlled with ciclosporin, oral prednisone and topical corticosteroids, when lupus anticoagulant was detected at another hospital) -- presented 4 months a” View full resource at content.karger.com
Most Recently Shared on January 29, 2010 at 2:05 pm By:
PsoriasisTx.com Health Site and Dermatology
Anti-TNFs & Pregnancy http://bit.ly/9llbs3
NephSpace -- Nephrotic Syndrome & FSGS Support Group | NephCure
nephcure.org — “NephSpace -- Nephrotic Syndrome & FSGS Support Group | NephCure” View full resource at nephcure.org
Most Recently Shared on April 5, 2011 at 4:58 pm By:
NephCure Foundation Health Organization and Nephrology
NephSpace Online Community (beta) | NephCure http://fb.me/wMU4gz2N
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Cancer news and research via News-Medical.Net
-
News-Medical.Net
Stay up to date with the latest Oncology news and research via News-Medical.Net
-
News-Medical.Net
Medical News from Around the World
Advertisement
